ProQR Therapeutics (PRQR) Total Liabilities (2021 - 2024)
Historic Total Liabilities for ProQR Therapeutics (PRQR) over the last 4 years, with Q4 2024 value amounting to $84.8 million.
- ProQR Therapeutics' Total Liabilities fell 1827.8% to $84.8 million in Q4 2024 from the same period last year, while for Dec 2024 it was $84.8 million, marking a year-over-year decrease of 1827.8%. This contributed to the annual value of $85.9 million for FY2024, which is 1766.91% down from last year.
- Per ProQR Therapeutics' latest filing, its Total Liabilities stood at $84.8 million for Q4 2024, which was down 1827.8% from $103.8 million recorded in Q4 2023.
- In the past 5 years, ProQR Therapeutics' Total Liabilities ranged from a high of $51.2 billion in Q1 2021 and a low of $54.0 million during Q2 2021
- Over the past 4 years, ProQR Therapeutics' median Total Liabilities value was $103.8 million (recorded in 2023), while the average stood at $4.0 billion.
- The largest annual percentage gain for ProQR Therapeutics' Total Liabilities in the last 5 years was 8205.81% (2022), contrasted with its biggest fall of 9980.26% (2022).
- Over the past 4 years, ProQR Therapeutics' Total Liabilities (Quarter) stood at $110.2 million in 2021, then dropped by 3.14% to $106.8 million in 2022, then decreased by 2.75% to $103.8 million in 2023, then decreased by 18.28% to $84.8 million in 2024.
- Its Total Liabilities was $84.8 million in Q4 2024, compared to $103.8 million in Q4 2023 and $104.2 million in Q3 2023.